Cardiovascular diseases are the leading cause of death worldwide. Approximately 85% of
all deaths from cardiovascular disease are due to acute myocardial infarction (AMI) and …

An increased plasma level of low-density lipoprotein (LDL) is a well-known risk factor for
endothelial dysfunction and atherosclerosis. 1 The proatherosclerotic potential of LDL may …

Atherosclerosis, the underlying cause of cardiovascular disease (CVD), is a worldwide
cause of morbidity and mortality. Reducing ApoB-containing lipoproteins—chiefly, LDL (low …

Abstract LOX‐1 (lectin‐like oxidized low‐density lipoprotein receptor‐1; also known as
OLR1) is the dominant receptor that recognizes and internalizes oxidized low‐density …

Oxidized low-density lipoprotein (LDL) exhibits various biological activities and accumulates
in atheromas. LOX-1 (lectin-like oxidized LDL receptor) is the receptor that mediates …

Oxidatively modified low-density lipoprotein (oxLDL) is implicated in the pathogenesis of
atherosclerosis. Endothelial dysfunction is the initial change in the vascular wall that induces …

Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1), one of the scavenger
receptors for oxidized low-density lipoprotein cholesterol (ox-LDL), plays a crucial role in the …

LOX-1 is an endothelial receptor for oxidized low-density lipoprotein (oxLDL), a key
molecule in the pathogenesis of atherosclerosis. The basal expression of LOX-1 is low but …

Background: Lectin-like oxidized LDL receptor-I (LOX-1), a novel receptor for oxidized low-
density lipoprotein, mediates oxidized low-density lipoprotein-induced apoptosis of …

Lectin-like oxidized low-density lipoprotein (LDL) receptor-1 (LOX-1) was initially identified
as the major receptor for oxidized LDL (OxLDL) in endothelial cells. Its inducible expression …